Author:
KHAMESRA RENU,PANCHAL AKSHAY
Abstract
Objectives: The objectives of the study were to assess the serum levels of uric acid in patients of migraine and to correlate the levels of uric acid with duration and severity of migraine.
Methods: This observational study was conducted in patients with complaint of headache, due to migraine who attended neurology and general medicine out patients department of tertiary care teaching hospital of Udaipur, Rajasthan. Uric acid levels were compared between both the genders with respect to age group, frequency of attack, and duration of migraine. Uric acid levels were also correlated with different parameters.
Results: A total of 500 patients were evaluated during the study period of 2 years. Mean uric acid in male patients was 5.02±1.40 mg/dl, and in females it was 4.99±1.39 mg/dl. Uric acid levels in male and female patients were found non-significant across all age groups, with duration of migraine and frequency of migraine attack (p>0.05). There was a significant correlation between uric acid levels and migraine severity in present study (p˂0.05), but there was no correlation with age, duration of migraine, and frequency of migraine attacks per month (p>0.05).
Conclusion: The study concluded that uric acid levels are within normal range in all age group as well as either of gender in patients of migraine. Hence, there is no relation between uric acid and duration and frequency of migraine but positive correlation with severity of migraine.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference21 articles.
1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the international headache society. Cephalalgia 1988;8 Suppl 7:1-96.
2. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9. doi: 10.1212/01. wnl.0000252808.97649.21, PMID 17261680
3. Abu-arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: A systematic review of population-based studies. Dev Med Child Neurol 2010;52:1088-97. doi: 10.1111/j.1469-8749.2010.03793.x, PMID 20875042
4. Shaik MM, Gan SH. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. BioMed Res Int 2015;2015:469529. doi: 10.1155/2015/469529, PMID 25815319
5. Le H, Tfelt-Hansen P, Russell MB, Skytthe A, Kyvik KO, Olesen J. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 2011;31:43-64. doi: 10.1177/0333102410373159, PMID 20974590